Cancer drug developer Inhibrx raises $40 million May 28, 2019 sandiegobiotech News Comments Off on Cancer drug developer Inhibrx raises $40 million Cancer drug developer Inhibrx raises $40 million Play Episode Pause Episode Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds 00:00 / Subscribe Share RSS Feed Share Link Embed Using an array of technologies, San Diego biotech Inhibrx is attacking a wide variety of cancers